Dystrophic Epidermolysis Bullosa

TGM1-deficient ARCI

Junctional Epidermolysis Bullosa

Additional Dermatological Indications

Netherton Syndrome


We strive to be the leader in the development of novel and proprietary “off the shelf” gene therapy products to fight some of the world’s most serious skin diseases.


To develop transformative, innovative, and science-based viral gene therapy products and processes to dramatically improve people’s lives.